Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
President | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 06/22–06/24 | 06/24 | 31,431 sh4 trades | $27.92avg. | $877,525.59 | −3.4% |
Alexander AzoyChief Accounting Officer | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 06/01 | 06/01 | 2,562 sh | $25.77 | $66,022.74 | −6.1% |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 05/11 | 05/12 | 7,763 sh | $25.63 | $198,965.69 | −8.4% | |
President | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 01/05 | 01/07 | 31,823 sh3 trades | $21.41avg. | $681,341.82 | −3.3% |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/31 | 01/02 | 6,552 sh | $23.38 | $153,185.76 | −8.8% | |
Chief Accounting Officer | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/18 | 25/12/18 | 8,832 sh3 trades | $22.13avg. | $195,442.71 | −32.3% |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/17 | 25/12/18 | 54,691 sh2 trades | $22.01avg. | $1,203,847.4 | −2.4% | |
President | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/17 | 25/12/18 | 21,208 sh2 trades | $22.01avg. | $466,826.28 | −5.8% |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/17 | 25/12/18 | 12,662 sh2 trades | $22.01avg. | $278,713.36 | −14.5% | |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/17 | 25/12/18 | 21,208 sh2 trades | $22.01avg. | $466,826.28 | −9.9% | |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/17 | 25/12/18 | 14,468 sh2 trades | $22.01avg. | $318,466.64 | −10.4% | |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/17 | 25/12/18 | 9,546 sh2 trades | $22.01avg. | $210,124.8 | −12.7% | |
Juan C. JaenPresident | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/12/04 | 25/12/05 | 82,997 sh | $24.71 | $2,050,855.87 | −8.0% |
Alexander AzoyChief Accounting Officer | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/11/26 | 25/12/01 | 1,900 sh | $26.00 | $49,400 | −6.5% |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/11/26 | 25/11/26 | 5,000 sh | $25.00 | $125,000 | −5.4% | |
President | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/11/17–25/11/18 | 25/11/19 | 50,000 sh3 trades | $20.26avg. | $1,012,837.28 | −4.6% |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/11/07 | 25/11/12 | 50,291 sh | $18.97 | $954,020.27 | −19.0% | |
Juan C. JaenPresident | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/10/30 | 25/11/03 | 4,314 sh | $20.32 | $87,660.48 | −0.4% |
President | Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/10/28–25/10/29 | 25/10/30 | 96,859 sh4 trades | $20.76avg. | $2,010,714.81 | −8.2% |
Arcus BiosciencesRCUS | Open-market sale10b5-1 plan | 25/10/28 | 25/10/29 | 5,000 sh | $20.00 | $100,000 | −5.1% |
